The 20% reduction in major adverse cardiovascular events justifies long-term use even independent of weight loss effects
This is called Prior Authorization, or PA
If the oral form is unavailable, your clinician can offer the injection form, and you may decline for a full refund
Back to Part 1 Part 1 of the guide covers the mechanism, the portal-peripheral mismatch, and how to read the U/kg trend over time.
More conservative estimates place approval in early to mid 2027
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
